Newsletter

Medisafe 1 Technologies (MFTH.OB) is a developer of a patented medical assembly with a locking mechanism to prevent unauthorized administration of drug or medicinal substance by hypodermic needle. The locking mechanism acts as a protector and only allows the substance to be released from the hypodermic needle after positive pre-matching between the substance and the specific patient.

MFTH's technology has the potential to be adopted as a standard in all major markets as a device to eliminate errors from injectable medication. The system can be applied not only to hypodermic needles but to any assembly that store medicine or substance that can be injected into patients.

Up to 98,000 American dies each year due to medical errors by healthcare professionals. Direct annual cost of preventable drug related motality and morbidity is about $177.4 billion. MFTH technology can play a significant role in reducing these liabilities.

Medisafe 1 Solution

• Protector device with locking mechanism ensures substance is only released from the hypodermic needle after positive technology-based pre-matching with the specific patient, using bar code technology.
• Protector fits over proportion of medicine assembly
• Protector includes bar code and locking element
• Locking element released electronically on positive match

Major Recent Business Developments

• Company has passed due diligence stage, signed LOI with Centurion Private Equity and expect to sign a final agreement for a $5,000,000 equity investment (Read more...)
• Possible collaboration with multinational medical supplier, Becton, Dickenson and Company (Read more...)
• Received a buy-out of all the outstanding shares of the Company at $0.33 per share subject to final due diligence (Read more...)

Medisafe 1's patented technology could potentially reduce significant amount of healthcare problems due to wrongful administration of medicine. The annual potential addressable market in the US alone is approximately $1.4 billion. The Company is in its early stage of development and could aggressively grow with the anticipated $5 million in funding. Keep a close watch on MFTH. The stock is currently trading around $0.13 and could move up quickly once some of the recent developments solidified.

DISCLAIMER: Never invest in any stock featured on our website or newsletters unless you can afford to lose your entire investment.

Through the use of this newsletter you agree to hold HotMicrocaps.com and its affiliates harmless and to completely release them from any and all liabilities due to any and all losses, damages, or injuries (monetary or otherwise) that you may incur. This does not represent an offer to buy or sell any security. HotMicrocaps.com and its affiliates are neither registered broker dealer nor investment advisors. All information on featured companies are provided by the companies profiled, or is available from public sources. HotMicrocaps.com has made the strongest effort to provide accurate, factual and complete information on its website and newsletters but neither HotMicrocaps.com nor any of the companies mentioned can guarantee the total accuracy of the information presented. Neither HotMicrocaps.com nor any of the companies profiled here assume any responsibility for the information on HotMicrocaps.com’s website or its newsletters. HotMicrocaps.com has been compensated by a third party eight thousand five hundred dollars and expected to receive an additional four thousand dollars for MFTH marketing services. The third party may have shares and may liquidate them which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the featured company. HotMicrocaps.com’s affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice which may negatively affect the stock price. HotMicrocaps.com encourages readers and investors to supplement the information in this newsletter with their own due diligence and professional advice. For full disclaimer, please visit http://www.hotmicrocaps.com/disclaimer.html.